Polymorphisms of DRD2 and DRD3 genes and Parkinson's disease: A meta-analysis.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Biomedical Reports

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/BR.2014.220PMID 24649110PMCID PMC3917740
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease

  2014cited by this paper
• Power failure: why small sample size undermines the reliability of neuroscience

  2013cited by this paper
• The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism

  2013cited by this paper
• Lack of association of IL-6 polymorphism with rheumatoid arthritis/type 1 diabetes: a meta-analysis.

  2013cited by this paper
• The impact of registration accuracy on imaging validation study design: A novel statistical power calculation

  2013cited by this paper
• The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis

  2013cited by this paper
• Dopamine transporter imaging with [123I]FP-CIT (DaTSCAN) in Parkinson's disease with depressive symptoms: a biological marker for causal relationships?

  2013cited by this paper
• Quality of Sleep in Patients with Parkinson's Disease

  2013cited by this paper
• Dopaminergic modulation of memory and affective processing in Parkinson depression.

  2013cited by this paper
• Etiologies of Parkinsonism in a Century‐Long Autopsy‐Based Cohort

  2013cited by this paper
• Acetaldehyde and parkinsonism: role of CYP450 2E1

  2013cited by this paper
• Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database

  2012cited by this paper
• Meta-analysis of TYK2 gene polymorphisms association with susceptibility to autoimmune and inflammatory diseases

  2011cited by this paper
• Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population

  2011cited by this paper
• Etiology and pathogenesis of Parkinson's disease

  2011cited by this paper
• Differential genetic susceptibility in diphasic and peak‐dose dyskinesias in Parkinson's disease

  2011cited by this paper
• Epidemiology and etiology of Parkinson’s disease: a review of the evidence

  2011cited by this paper
• Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.

  2011cited by this paper
• Comment on: Heterogeneity in meta-analysis should be expected and appropriately quantified.

  2010cited by this paper
• The Genetics of Parkinson Disease

  2010cited by this paper
• Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease

  2009cited by this paper
• Stridor in Parkinson's disease: a case of ‘dry drowning’?

  2009cited by this paper
• Polymorphism in environment responsive genes and association with Parkinson disease

  2008cited by this paper
• Pain sensitivity and descending inhibition of pain in Parkinson’s disease

  2008cited by this paper
• Pooled analysis of tobacco use and risk of Parkinson disease.

  2007cited by this paper
• Novel, replicated associations between dopamine D3 receptor gene polymorphisms and schizophrenia in two independent samples.

  2006cited by this paper
• Genetic testing in Parkinson's disease

  2005cited by this paper
• Arlequin (version 3.0): An integrated software package for population genetics data analysis

  2005influential reference
• A systematic review of prevalence studies of dementia in Parkinson's disease

  2005cited by this paper
• Progress in searching for susceptibility loci and genes for smoking‐related behaviour

  2004cited by this paper
• The genetic basis for smoking behavior: a systematic review and meta-analysis.

  2004cited by this paper
• Genetics of Parkinson disease

  2004cited by this paper
• D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes

  2003cited by this paper
• Parkinson's Disease Mechanisms and Models

  2003cited by this paper
• Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity.

  2003cited by this paper
• Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease

  2003cited by this paper
• Risk tables for parkinsonism and Parkinson's disease.

  2002cited by this paper
• Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson's disease.

  2002cited by this paper
• Allelic association between the DRD2 TaqI A polymorphism and Parkinson's disease

  2000cited by this paper
• The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease

  2000cited by this paper
• Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism

  2000cited by this paper
• Polymorphisms of dopamine D_3 receptor gene and parkinson disease

  2000cited by this paper
• Etiology and pathogenesis of Parkinson's disease.

  1999cited by this paper
• The D2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes.

  1998cited by this paper
• D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.

  1997cited by this paper
• Dopamine receptors and brain function.

  1996cited by this paper
• Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease

  1995cited by this paper
• No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms.

  1994cited by this paper
• Dopamine D3 and D4 receptor gene polymorphisms and Parkinson's disease.

  1993cited by this paper
• Paraganglial cells of urinary bladder and prostate: potential diagnostic problem.

  1990cited by this paper

• The importance of dopamine levels and single-nucleotide polymorphism within COMT, DRD1 and DRD2 genes in obstructive sleep apnoea

  2025cites this paper
• Antinociceptive role of the thalamic dopamine D3 receptor in descending modulation of intramuscular formalin-induced muscle nociception in a rat model of Parkinson's disease.

  2024cites this paper
• Lo-Hi: Practical ML Drug Discovery Benchmark

  2023cites this paper
• Prediction of drug amount in Parkinson's disease using hybrid machine learning systems and radiomics features

  2023cites this paper
• Approach to the specificity and selectivity between D2 and D3 receptors by mutagenesis and binding experiments part I: Expression and characterization of D2 and D3 receptor mutants

  2022cites this paper
• Application of novel hybrid machine learning systems and radiomics features for non-motor outcome prediction in Parkinson’s disease

  2022cites this paper
• Influence of COMT (rs4680) and DRD2 (rs1076560, rs1800497) Gene Polymorphisms on Safety and Efficacy of Methylphenidate Treatment in Children with Fetal Alcohol Spectrum Disorders

  2022cites this paper
• Polymorphisms of Dopamine Receptor Genes and Parkinson’s Disease: Clinical Relevance and Future Perspectives

  2021cites this paper
• Genetic Pathways Involved in the Pathogenesis of Parkinson's Disease.

  2021cites this paper
• Longitudinal clustering analysis and prediction of Parkinson's disease progression using radiomics and hybrid machine learning.

  2021cites this paper
• Nardosinone Alleviates Parkinson's Disease Symptoms in Mice by Regulating Dopamine D2 Receptor

  2021cites this paper
• Feature selection and machine learning methods for optimal identification and prediction of subtypes in Parkinson's disease

  2021cites this paper
• Regulatory rare variants of the dopaminergic gene ANKK1 as potential risk factors for Parkinson’s disease

  2021cites this paper
• Differences in MTHFR and LRRK2 variant’s association with sporadic Parkinson’s disease in Mexican Mestizos correlated to Native American ancestry

  2021cites this paper
• Influence of serum concentration in retinoic acid and phorbol ester induced differentiation of SH-SY5Y human neuroblastoma cell line

  2020cites this paper
• Contribution of functional dopamine D2 and D3 receptor variants to motor and non-motor symptoms of early onset Parkinson's disease.

  2020cites this paper
• Robust identification of Parkinson's disease subtypes using radiomics and hybrid machine learning

  2020cites this paper
• Association of Multiple Dopamine D3 Receptor Gene 3′UTR Polymorphisms with Susceptibility to Parkinson's Disease and Clinical Efficacy of Piribedil Therapy

  2020cites this paper
• Axonal degeneration in Parkinson's disease – Basal ganglia circuitry and D2 receptor availability

  2019cites this paper
• Analysis of Protein-Protein Interaction Using Skyline Query on Parkinson Disease

  2019cites this paper
• Association between the DRD2 TaqIA gene polymorphism and Parkinson disease risk: an updated meta-analysis

  2019influential citation
• Optimized machine learning methods for prediction of cognitive outcome in Parkinson's disease

  2019cites this paper
• Association between dopamine receptor D2 TaqIA polymorphism and Parkinson disease risk: a meta-analysis.

  2019influential citation
• Dopamine D3 receptor: a neglected participant in Parkinson Disease pathogenesis and treatment?

  2019cites this paper
• Dopamine receptor D2 genetic variations is associated with the risk and clinicopathological variables of urothelial cell carcinoma in a Taiwanese population

  2018cites this paper
• Association of Brain-Derived Neurotrophic Factor (BDNF) Gene Snps G196A and C270T with Alzheimer’s Disease: A Meta-Analysis

  2017cites this paper
• Association of the DRD2 CAn-STR and DRD3 Ser9Gly polymorphisms with Parkinson's disease and response to dopamine agonists.

  2017cites this paper
• Efficient and biologically relevant consensus strategy for Parkinson’s disease gene prioritization

  2016cites this paper
• Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms.

  2016cites this paper
• [The association of the DRD3 gene with Parkinson's disease].

  2016cites this paper
• Advances in understanding genomic markers and pharmacogenetics of Parkinson’s disease

  2016cites this paper
• Association of BDNF and BCHE with Alzheimer's disease: Meta-analysis based on 56 genetic case-control studies of 12,563 cases and 12,622 controls.

  2015cites this paper
• INSTITUTE OF NEUROSCIENCE OF CASTILLA Y LEÓN Laboratory of Audiomotor disorders ENGLISH SUMMARY Sensorimotor Alterations in Neurodegenerative Disease

  2015cites this paper
• Meta-analyses of seven GIGYF2 polymorphisms with Parkinson's disease.

  2014cites this paper